Vera Therapeutics, Inc. Class A Common Stock (VERA)
PHARMACEUTICAL PREPARATIONS
Vera Therapeutics, Inc. Class A Common Stock (VERA) is listed on Nasdaq, where it has traded since May 14, 2021.
- Listed On
- Nasdaq
- Listed Since
- May 14, 2021
- Employees
- 361
- Market Cap
- $2.2B
About Vera Therapeutics, Inc. Class A Common Stock
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 211 institutions reported holding VERA, with 77.9 million shares worth $3.3 billion in aggregate. The largest reported holder was BlackRock, with 5.7 million shares worth $246.6 million. Of the 5 largest holders listed below, 2 added shares and 3 reduced their positions during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| BlackRock | 5,747,760 | $247M | Added 12.96% |
| Avoro Capital Advisors | 5,723,888 | $246M | Reduced 2.8% |
| State Street | 4,148,786 | $178M | Added 23.34% |
| T. Rowe Price | 4,012,936 | $172M | Reduced 12.27% |
| Deep Track Capital | 4,000,000 | $172M | Reduced 2.58% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is VERA?
Vera Therapeutics, Inc. Class A Common Stock (VERA) is listed on Nasdaq, where it has traded since May 14, 2021.
Who are the largest institutional holders of VERA?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of VERA were BlackRock, Avoro Capital Advisors and State Street.
How many institutions own VERA?
211 institutions reported a position in VERA for the quarter ended June 30, 2026, worth $3.3 billion in total.
Did institutions buy or sell VERA last quarter?
Of the 5 largest reported holders, 2 added shares and 3 reduced their positions during the quarter. Every reported holder and its change is on the SentiSense ownership page for VERA.
Every reported institutional holder, plus insider and congressional trades in VERA, on SentiSense.